Intensity Therapeutics Competitors and Similar CompaniesClear all
Intensity Therapeutics's competitors and similar companies include Acrivon.
 Intensity Therapeutics Intensity Therapeutics is a biotechnology company that develops intratumoral immunotherapy products. |  Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. | |
Founding Date | Founding Date 2012 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Shelton, US HQ | Locations Watertown, US HQ Lund, SE |
Employees | Employees 5150% increase | Employees 415% increase |
Valuation ($) | Valuation ($) 42.7 m | Valuation ($) 256.1 m |
Financial | ||
Net income | Net income ($11.6m) (FY, 2025) | Net income ($77.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Acrivon
HQ
Watertown, US
Employees
41↑ 5% increase
Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.
View company